Eoin R. Feeney

2.2k total citations
53 papers, 1.1k citations indexed

About

Eoin R. Feeney is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Eoin R. Feeney has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 16 papers in Virology and 16 papers in Epidemiology. Recurrent topics in Eoin R. Feeney's work include HIV-related health complications and treatments (15 papers), HIV Research and Treatment (12 papers) and HIV/AIDS drug development and treatment (8 papers). Eoin R. Feeney is often cited by papers focused on HIV-related health complications and treatments (15 papers), HIV Research and Treatment (12 papers) and HIV/AIDS drug development and treatment (8 papers). Eoin R. Feeney collaborates with scholars based in Ireland, United States and United Kingdom. Eoin R. Feeney's co-authors include Raymond T. Chung, Patrick Mallon, Raymond T. Chung, Jennifer Y. Chen, John S. Lambert, Jane A. O’Halloran, Aoife G. Cotter, David W. Kubiak, Claudette Satchell and G. Ralph Corey and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Eoin R. Feeney

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eoin R. Feeney Ireland 15 486 421 397 346 290 53 1.1k
Antonio Chirianni Italy 17 292 0.6× 553 1.3× 444 1.1× 170 0.5× 429 1.5× 70 1.1k
Jean‐Paul Viard France 20 352 0.7× 654 1.6× 413 1.0× 76 0.2× 293 1.0× 39 1.3k
Dariela Micheloud Spain 18 335 0.7× 247 0.6× 143 0.4× 188 0.5× 172 0.6× 48 780
Carolynne Schwarze‐Zander Germany 20 570 1.2× 252 0.6× 195 0.5× 463 1.3× 167 0.6× 57 1.1k
Elina Teicher France 19 458 0.9× 459 1.1× 268 0.7× 527 1.5× 168 0.6× 41 1.1k
Henning Drechsler United States 14 267 0.5× 614 1.5× 532 1.3× 114 0.3× 382 1.3× 25 1.0k
Vincenzo Colangeli Italy 25 436 0.9× 1.2k 2.9× 775 2.0× 93 0.3× 822 2.8× 81 2.0k
Caroline Lascoux‐Combe France 22 944 1.9× 448 1.1× 183 0.5× 764 2.2× 297 1.0× 64 1.5k
François Raffi France 15 416 0.9× 856 2.0× 1.0k 2.5× 72 0.2× 660 2.3× 26 1.7k
Gabriella Verucchi Italy 21 1.5k 3.0× 286 0.7× 152 0.4× 1.5k 4.3× 173 0.6× 86 2.0k

Countries citing papers authored by Eoin R. Feeney

Since Specialization
Citations

This map shows the geographic impact of Eoin R. Feeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eoin R. Feeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eoin R. Feeney more than expected).

Fields of papers citing papers by Eoin R. Feeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eoin R. Feeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eoin R. Feeney. The network helps show where Eoin R. Feeney may publish in the future.

Co-authorship network of co-authors of Eoin R. Feeney

This figure shows the co-authorship network connecting the top 25 collaborators of Eoin R. Feeney. A scholar is included among the top collaborators of Eoin R. Feeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eoin R. Feeney. Eoin R. Feeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Léon, A., Peter T. Doran, Alan Landay, et al.. (2025). Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccination. EBioMedicine. 113. 105622–105622. 4 indexed citations
2.
Léon, A., Alan Landay, Liêm Binh Luong Nguyen, et al.. (2025). Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara–Bavarian Nordic Vaccination. Open Forum Infectious Diseases. 12(9). ofaf536–ofaf536. 1 indexed citations
3.
Katoto, Patrick DMC, Bruce Kirenga, Wilber Sabiiti, et al.. (2025). Immune Response to MVA-BN Vaccination for Mpox: Current Evidence and Future Directions. Vaccines. 13(9). 930–930. 1 indexed citations
4.
Léon, A., et al.. (2025). Breakthrough atypical mpox in a vaccinated individual with high antibody titres. The Lancet Infectious Diseases. 25(7). e439–e439. 2 indexed citations
5.
Brown, S. A., Keith Gaynor, Jessica Bramham, et al.. (2024). A psychological model of predictive factors of distress following long COVID. Journal of Affective Disorders. 373. 394–402.
6.
Hassanin, Ahmed, et al.. (2024). Predictors of Successful Antibiotic Treatment of Osteomyelitis in Diabetic Forefoot Infection. Acta Diabetologica. 62(5). 661–670.
7.
8.
9.
10.
Ghosh, Tarini Shankar, A. Léon, Junhui Li, et al.. (2023). Associations between host microbiome and inflammation suggest role for host microbiome in driving COVID-19 disease severity. Microbes and Infection. 26(3). 105247–105247.
11.
Feeney, Eoin R., et al.. (2022). Development of a coordinated acute diabetic foot pathway for management of acute diabetic foot infection and ulceration. Irish Journal of Medical Science (1971 -). 192(1). 161–167. 2 indexed citations
12.
Callanan, Ian, et al.. (2021). Changing attitudes towards annual influenza vaccination amongst staff in a Tertiary Care Irish University Hospital. Irish Journal of Medical Science (1971 -). 191(2). 629–636. 9 indexed citations
13.
Holmes, Jacinta A., Eoin R. Feeney, Annie J. Kruger, et al.. (2018). Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. The Journal of Infectious Diseases. 218(9). 1394–1403. 36 indexed citations
14.
Feeney, Eoin R., Émilie Capel, Jacqueline Capeau, et al.. (2016). Improved adipose tissue function with initiation of protease inhibitor-only ART. Journal of Antimicrobial Chemotherapy. 71(11). 3212–3221. 5 indexed citations
15.
Bility, Moses T., Kouki Nio, Feng Li, et al.. (2016). Chronic hepatitis C infection–induced liver fibrogenesis is associated with M2 macrophage activation. Scientific Reports. 6(1). 39520–39520. 56 indexed citations
16.
Feeney, Eoin R. & Raymond T. Chung. (2015). The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C. Digestive Diseases and Sciences. 60(8). 2232–2235. 1 indexed citations
17.
Feeney, Eoin R., Marit G. A. van Vonderen, Ferdinand W.N.M. Wit, et al.. (2012). Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA. AIDS. 26(17). 2165–2174. 15 indexed citations
18.
Satchell, Claudette, Jane A. O’Halloran, Aoife G. Cotter, et al.. (2011). Increased Platelet Reactivity in HIV-1–Infected Patients Receiving Abacavir-Containing Antiretroviral Therapy. The Journal of Infectious Diseases. 204(8). 1202–1210. 69 indexed citations
19.
Feeney, Eoin R. & Patrick Mallon. (2011). Insulin resistance in treated HIV infection. Best Practice & Research Clinical Endocrinology & Metabolism. 25(3). 443–458. 37 indexed citations
20.
Feeney, Eoin R. & Patrick Mallon. (2010). Impact of Mitochondrial Toxicity of HIV-1 Antiretroviral Drugs on Lipodystrophy and Metabolic Dysregulation. Current Pharmaceutical Design. 16(30). 3339–3351. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Chirianni Breakdown of academic impact, for papers by Jean‐Paul Viard Breakdown of academic impact, for papers by Dariela Micheloud Breakdown of academic impact, for papers by Carolynne Schwarze‐Zander Breakdown of academic impact, for papers by Elina Teicher Breakdown of academic impact, for papers by Henning Drechsler Breakdown of academic impact, for papers by Vincenzo Colangeli Breakdown of academic impact, for papers by Caroline Lascoux‐Combe Breakdown of academic impact, for papers by François Raffi Breakdown of academic impact, for papers by Gabriella Verucchi
Rankless by CCL
2026